These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 10425010

  • 21. Individualized heparin monitoring and management reduces protamine requirements in cardiac surgery on minimal invasive extracorporeal circulation; A prospective randomized study.
    Gkiouliava A, Argiriadou H, Antonitsis P, Goulas A, Papapostolou E, Sarridou D, Karapanagiotidis GT, Anastasiadis K.
    Perfusion; 2024 Nov; 39(8):1595-1604. PubMed ID: 37776194
    [Abstract] [Full Text] [Related]

  • 22. Reversal of heparin after cardiac surgery: protamine titration using a statistical model.
    Davidsson FÖ, Johagen D, Appelblad M, Svenmarker S.
    J Cardiothorac Vasc Anesth; 2015 Nov; 29(3):710-4. PubMed ID: 25813226
    [Abstract] [Full Text] [Related]

  • 23. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J.
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [Abstract] [Full Text] [Related]

  • 24. Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial.
    Kjellberg G, Holm M, Fux T, Lindvall G, van der Linden J.
    J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):985-992. PubMed ID: 30206011
    [Abstract] [Full Text] [Related]

  • 25. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P, Bakchoul T, Wilhelm J, Wagner A, Wollbrück M, Böning A, Sachs U.
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [Abstract] [Full Text] [Related]

  • 26. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
    Jobes DR, Aitken GL, Shaffer GW.
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
    [Abstract] [Full Text] [Related]

  • 27. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
    Yamanishi H, Watanabe S, Hayashi K, Tomioka H, Minami M, Nozaki Y, Aoki T, Kawai Y, Kishino K, Ohta S.
    Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
    [Abstract] [Full Text] [Related]

  • 28. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T, Olson PJ, Szlam F, Ramsay JG, Levy JH.
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y.
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [Abstract] [Full Text] [Related]

  • 31. Clinical effects of different protamine doses after cardiopulmonary bypass.
    Svenarud P, Øvrum E.
    Asian Cardiovasc Thorac Ann; 2002 Jun; 10(2):119-23. PubMed ID: 12079933
    [Abstract] [Full Text] [Related]

  • 32. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP, Castellani WJ, Hodges ED, Yelverton S.
    Thromb Haemost; 1991 Aug 01; 66(2):213-7. PubMed ID: 1771614
    [Abstract] [Full Text] [Related]

  • 35. Platelet damage by protamine and the protective effect of prostacyclin: an experimental study in dogs.
    Velders AJ, Wildevuur CR.
    Ann Thorac Surg; 1986 Aug 01; 42(2):168-71. PubMed ID: 3527093
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Accurate protamine:heparin matching (not just smaller protamine doses) decreases postoperative bleeding in cardiac surgery; results from a high-volume academic medical center.
    Vespe MW, Stone ME, Lin HM, Ouyang Y.
    Perfusion; 2024 Oct 01; 39(7):1335-1347. PubMed ID: 37493300
    [Abstract] [Full Text] [Related]

  • 38. Protamine--the need to determine the dose. Comparison of a simple protamine titration method with an empirical dose regimen for reversal of heparinisation following cardiopulmonary bypass.
    Keeler JF, Shah MV, Hansbro SD.
    Anaesthesia; 1991 Nov 01; 46(11):925-8. PubMed ID: 1750591
    [Abstract] [Full Text] [Related]

  • 39. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M, Kobayashi S, Niwaya K, Hamada Y, Kitamura S.
    Artif Organs; 1996 Jul 01; 20(7):767-76. PubMed ID: 8828766
    [Abstract] [Full Text] [Related]

  • 40. Protamine titration to optimize heparin antagonization after cardiopulmonary bypass.
    Foubert R, Van Vaerenbergh G, Cammu G, Buys S, De Mey N, Lecomte P, Bouchez S, Rex S, Foubert L.
    Perfusion; 2024 Sep 01; 39(6):1062-1069. PubMed ID: 36503295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.